Matrix metalloproteinase-3 contributes to vulnerability of the nigral dopaminergic neurons

Neurochemistry International

Volumn 56, Issue 1, 2010, Pages 161-167

  Kim, Sung Tae ^a   Kim, Eun Mee ^a   Choi, Ji Hyun ^a   Son, Hyo Jin ^a   Ji, In Jung ^a   Joh, Tong H ^b   Chung, Sun Ju ^a   Hwang, Onyou ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Dopaminergic neuron; Knockout; Matrix metalloproteinase 3; Substantia nigra; Tyrosine hydroxylase

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; STROMELYSIN; TETRAHYDROBIOPTERIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE UPTAKE; DOPAMINERGIC NERVE CELL; EMBRYO; ENZYME ACTIVITY; IMMUNOREACTIVITY; KNOCKOUT GENE; MALE; MOUSE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; SUBSTANTIA NIGRA; WILD TYPE;

ANIMALS; CELL COUNT; CELLS, CULTURED; CORPUS STRIATUM; CYTOPROTECTION; DENDRITES; DISEASE MODELS, ANIMAL; DOPAMINE; DOWN-REGULATION; GAMMA-AMINOBUTYRIC ACID; MALE; MATRIX METALLOPROTEINASE 3; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE DEGENERATION; NEURONS; PARKINSON DISEASE; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

MUS;

EID: 73449128954     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.09.014     Document Type: Article

References (27)

1. Bouchez G., Sensebé L., Vourc'h P., Garreau L., Bodard S., Rico A., Guilloteau D., Charbord P., Besnard J.C., and Chalon S. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease. Neurochem. Int. 52 (2008) 1332-1342
2. Choi, D.H., Joh, T.H., Beal, M.F., Hwang, O., Kim, Y.S., in preparation. Matrix metalloproteinase-3 cleavage of DJ-1 in oxidative stress-induced dopaminergic cell death.
3. Choi H.J., Kim S.W., Lee S.Y., and Hwang O. Dopamine-dependent cytotoxicity of tetrahydrobiopaterin: a possible mechanism for selective neurodegeneration in Parkinson's disease. J. Neurochem. 86 (2003) 143-152
4. Choi H.J., Lee S.Y., Cho Y., and Hwang O. Inhibition of vesicular monoamine transporter enhances vulnerability of dopaminergic cells: relevance to Parkinson's disease. Neurochem. Int. 46 (2005) 329-335
5. Choi D.H., Kim E.M., Son H.J., Joh T.H., Kim Y.S., Beal M.F., and Hwang O. A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells. J. Neurochem. 106 (2008) 405-415
6. Choi H.J., Jang Y.J., Kim H.J., and Hwang O. Tetrahydrobiopterin is released from and causes preferential death of catecholaminergic cells by oxidative stress. Mol. Pharmacol. 58 (2000) 633-640
7. Davis M.D., and Kaufman S. Products of the tyrosine-dependent oxidation of tetrahydrobiopterin by rat liver phenylalanine hydroxylase. Arch. Biochem. Biophys. 304 (1993) 9-16
8. Ethell I.M., and Ethell D.W. Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets. J. Neurosci. Res. 85 (2007) 2813-2823
9. Fearnley J.M., and Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114 (1991) 2283-2301
10. Han J.M., Lee Y.J., Lee S.Y., Kim E.M., Moon Y., Kim H.W., and Hwang O. Protective effect of sulforaphane against dopaminergic cell death. J. Pharmacol. Exp. Therap. 321 (2007) 249-256
11. Hastings T.G., and Zigmond M.J. Loss of dopaminergic neurons in Parkinsonism: possible role of reactive dopamine metabolites. J. Neural Trans. Suppl. 49 (1997) 103-110
12. Hirsch E., Graybiel A.M., and Agrid Y.A. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334 (1988) 345-348
13. Kim S.T., Choi J.H., Chang J.W., Kim S.W., and Hwang O. Immobilization stress causes increases in tetrahydrobiopterin, dopamine, and neuromelanin and oxidative damage in the nigrostriatal system. J. Neurochem. 95 (2005) 89-98
14. Kim S.T., Choi J.H., Kim D., and Hwang O. Increases in TH immunoreactivity, neuromelanin and degeneration in the substantia nigra of middle aged mice. Neurosci. Lett. 396 (2006) 263-268
15. Kim S.W., Jang Y.J., Chang J.W., and Hwang O. Degeneration of the nigrostriatal pathway and induction of motor deficit by tetrahydrobiopter: an in vivo model relevant to Parkinson's disease. Neurobiol. Dis. 13 (2003) 167-176
16. Kim Y.S., Choi D.H., Block M.L., Lorenzl S., Yang L., Kim Y.J., Sugama S., Cho B.P., Hwang O., Browne S.E., Kim S.Y., Hong J.S., Beal M.F., and Joh T.H. A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration vie microglia activation. J. Fed. Am. Soc. Exp. Biol. 21 (2007) 179-187
17. Kim Y.S., Kim S.S., Cho J.J., Choi D.H., Hwang O., Shin D.H., Chun H.S., Beal M.F., and Joh T.H. Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia. J. Neurosci. 25 (2005) 3701-3711
18. Lauder J.M., Han V.K.M., Henderson P., and Verdoorn T. Prenatal ontogeny of the GABAergic systems in the rat brain: an immunocytochemical study. Neuroscience 19 (1986) 465-493
19. Lee S.Y., Moon Y., Choi D.H., Choi H.J., and Hwang O. Particular vulnerability of rat mesencephalic dopaminergic neurons to tetrahydrobiopterin: relevance to Parkinson's disease. Neurobiol. Dis. 25 (2007) 112-120
20. Levin J., Giese A., Boetzel K., Israel L., Högen T., Nübling G., Kretzschmar H., and Lorenzl S. Increased alpha-synuclein aggregation following limited cleavage by certain matrix metalloproteinases. Exp. Neurol. 215 (2009) 201-208
21. Liang C.L., Nelson O., Yazdani U., Pasbakhsh P., and German D.C. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons. J. Comp. Neurol. 473 (2004) 97-106
22. McGeer P.L., McGeer E.G., and Suzuki J.S. Aging and extrapyramidal function. Arch. Neurol. 34 (1977) 33-35
23. Mudgett J.S., Hutchinson N.I., Chartrain N.A., Forsyth A.J., McDonnell J., Singer I.I., Bayne E.K., Flanagan J., Kawka D., Shen C.F., Stevens K., Chen H., Trumbauer M., and Visco D.M. Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction. Arthritis Rheumat. 41 (1998) 110-121
24. Orb S., Wieacker J., Labarca C., Fonck C., Lester H.A., and Schwarz J. Knockin mice with Leu9'Ser alpha4-nicotinic receptors: substantia nigra dopaminergic neurons are hypersensitive to agonist and lost postnatally. Physiol. Genom. 18 (2004) 299-307
25. Sung J.Y., Park S.M., Lee C.-H., Um J.W., Lee H.J., Kim J., Oh Y.J., Lee S.-T., Paik S.R., and Chung K.C. Proteolytic cleavage of extracellular secreted α-synuclein via matrix metalloproteinases. J. Biol. Chem. 280 (2005) 25216-25224
26. Theissen B., Rajput A.H., Laverty W., and Desai H. Age, environments and the number of substantia nigra neurones. In: Streifler M.B., Korezyn A.D., Melamed E., and Youdim M.B.H. (Eds). Advances in Neurology: Parkinson's Disease: Anatomy, Pathology, and Therapy (1990), Raven Press, New York 201-206
27. Tooyama I., McGeer E.G., Kawamata T., Kimura H., and McGeer P.L. Retention of basic fibroblast growth factor immunoreactivity in dopaminergic neurons of the substantia nigra during normal ageing in humans contrasts with the loss in Parkinson's disease. Brain Res. 656 (1994) 165-168